Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II
Nucleic Acids Research · 08.05.2024 · 52 (8) · 4151-4166
DOI: 10.1093/nar/gkae069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 10.02.2024. Verfasst von Jaime A Espinoza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm…. Hauptthemen laut MEDLINE: Chromatin, DNA Topoisomerases, Type II, Intercalating Agents, RNA Polymerase II. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Vetenskapsrådet, Radiumhemmets forskningsfonder.
Abstract (Originalsprache)
In cancer therapy, DNA intercalators are mainly known for their capacity to kill cells by inducing DNA damage. Recently, several DNA intercalators have attracted much interest given their ability to inhibit RNA Polymerase I transcription (BMH-21), evict histones (Aclarubicin) or induce chromatin trapping of FACT (Curaxin CBL0137). Interestingly, these DNA intercalators lack the capacity to induce DNA damage while still retaining cytotoxic effects and stabilize p53. Herein, we report that these DNA intercalators impact chromatin biology by interfering with the chromatin stability of RNA polymerases I, II and III. These three compounds have the capacity to induce degradation of RNA polymerase II and they simultaneously enable the trapping of Topoisomerases TOP2A and TOP2B on the chromatin. In addition, BMH-21 also acts as a catalytic inhibitor of Topoisomerase II, resembling Aclarubicin. Moreover, BMH-21 induces chromatin trapping of the histone chaperone FACT and propels accumulation of Z-DNA and histone eviction, similarly to Aclarubicin and CBL0137. These DNA intercalators have a cumulative impact on general transcription machinery by inducing accumulation of topological defects and impacting nuclear chromatin. Therefore, their cytotoxic capabilities may be the result of compounding deleterious effects on chromatin homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 21 Stockholm, Sweden.
- Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.
ORCID-Profile: Jaime A Espinoza, Dimitris C Kanellis, Sheetanshu Saproo, Karla Leal, Jiri Bartek, Mikael S Lindström
Förderung
- Cancerfonden
- Vetenskapsrådet
- Radiumhemmets forskningsfonder
- Swedish Research Council
Zitieren
APA
Espinoza, J. A., Kanellis, D. C., Saproo, S., Leal, K., Martinez, J. F., Bartek, J., & Lindström, M. S. (2024). Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II. Nucleic Acids Research, 52(8), 4151-4166. https://doi.org/10.1093/nar/gkae069
Vancouver
Espinoza JA, Kanellis DC, Saproo S, Leal K, Martinez JF, Bartek J, et al. Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II. Nucleic Acids Research. 2024;52(8):4151-4166. doi:10.1093/nar/gkae069
BibTeX
@article{Espinoza2024,
author = {Espinoza, Jaime A and Kanellis, Dimitris C and Saproo, Sheetanshu and Leal, Karla and Martinez, Johana Fernandez and Bartek, Jiri and Lindström, Mikael S},
title = {Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {8},
pages = {4151--4166},
doi = {10.1093/nar/gkae069}
}
EUVIMED